Search for: "Gilead Sciences, Inc. v. Lee" Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2015, 9:59 pm by Patent Docs
Filing of IDS after Response to Restriction Requirement Constitutes Failure to Engage in Reasonable Efforts to Conclude Prosecution By Donald Zuhn -- Last week, in Gilead Sciences, Inc. v. [read post]
23 Jan 2019, 8:28 am by Lawrence B. Ebert
District Court for the Eastern District of Virginia.The district court determined that, based on thiscourt’s decision in Gilead Sciences, Inc. v. [read post]
30 Jan 2019, 10:15 am by Gene Quinn
A sensible ruling, and one the panel explained was entirely consistent with both the PTA statute and Gilead Sciences, Inc. v. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
13 Aug 2021, 4:00 am by Jim Sedor
Rand Paul revealed his wife bought stock in Gilead Sciences, which makes an antiviral drug used to treat COVID-19, in February 2020, before it was classified as a pandemic by the World Health Organization. [read post]